New drug aims to stop throat cancer from coming back
Disease control
Not yet recruiting
This study tests a new drug, Becotatug vedotin, against a standard chemotherapy pill (capecitabine) to see which is better at preventing cancer from returning in people with advanced nasopharyngeal cancer. About 218 adults who have already completed standard chemoradiation will b…
Phase: PHASE2 • Sponsor: Kai Hu • Aim: Disease control
Last updated May 11, 2026 20:41 UTC